Notice of Proposed Sale · 144
Corcept Therapeutics Incorporated
CORTNASDAQEQUITYCurrent
Notice of Proposed Sale
Structured filing — 144
primary_doc.xml
Notice of proposed sale. The proposed amounts below do not establish that a sale occurred.
Proposed-sale notice
- Issuer
- CORCEPT THERAPEUTICS INC
- Issuer CIK
- 0001088856
- SEC file number
- 000-50679
- Phone
- 650.688.8803
- Person for whose account securities are to be sold
- Mokari Atabak
- Relationships to issuer
- Officer
- Street
- 101 REDWOOD SHORES PARKWAY
- City
- REDWOOD CITY
- State / country code
- CA
- Postal code
- 94065
Securities proposed for sale
| Security | Proposed units | Aggregate market value | Units outstanding | Approximate sale date | Exchange | Broker / market maker |
|---|---|---|---|---|---|---|
| Common Stock | 40,000 | 4,588,556.00 | 108,098,397 | 07/30/2026 | Nasdaq | Stifel Nicolaus & Company Inc |
Broker / market maker — proposed row 1, entry 1
- Name
- Stifel Nicolaus & Company Inc
- Street
- 501 N Broadway
- City
- St. Louis
- State / country code
- MO
- Postal code
- 63102
Acquisition of securities to be sold
| Security | Acquired | Nature of acquisition | Acquired from | Amount acquired | Gift transaction | Payment date | Nature of payment |
|---|---|---|---|---|---|---|---|
| Common Stock | 02/13/2023 | Stock Option Exercises | Issuer | 40,000 | N | 02/13/2023 | Equity Compensation |
Sales reported in the preceding three months
| Seller | Security | Sale date | Amount sold | Gross proceeds |
|---|---|---|---|---|
| Atabak Mokari | Common Stock | 06/01/2026 | 40,000 | 2,800,004.00 |
| Atabak Mokari | Common Stock | 06/15/2026 | 40,000 | 3,245,900.00 |
| Atabak Mokari | Common Stock | 07/15/2026 | 40,000 | 3,508,276.00 |
Seller — prior-sale row 1, entry 1
- Name
- Atabak Mokari
- Street
- 101 REDWOOD SHORES PARKWAY
- City
- REDWOOD CITY
- State / country code
- CA
- Postal code
- 64065
Seller — prior-sale row 2, entry 1
- Name
- Atabak Mokari
- Street
- 101 REDWOOD SHORES PARKWAY
- City
- REDWOOD CITY
- State / country code
- CA
- Postal code
- 94065
Seller — prior-sale row 3, entry 1
- Name
- Atabak Mokari
- Street
- 101 REDWOOD SHORES PARKWAY
- City
- REDWOOD CITY
- State / country code
- CA
- Postal code
- 94065
Prior-sale reporting
- Nothing to report for the preceding three months
- N
Notice signature
- Notice date
- 07/30/2026
- Signed
- /s/ James Weimer, as a duly authorized representative of STIFEL, as attorney-in-fact for Atabak Mokari
- Plan adoption dates
- 12/12/2025
Company context
For over 25 years, Corcept has focused on cortisol modulation and its potential to treat patients with a wide variety of serious disorders and has discovered more than 1,000 proprietary selective cortisol modulators and glucocorticoid receptor antagonists. Corcept is conducting advanced clinical trials in patients with hypercortisolism, solid tumors, ALS and liver disease.